COKE vs UTI
Coca-Cola Consolidated vs Universal Technical Institute, Inc. — AI-powered side-by-side comparison
COKE
Coca-Cola Consolidated
63
Buy
VS
UTI
Universal Technical Institute, Inc.
53
Watch
| Metric | COKE | UTI |
|---|
| AI Score |
63
|
53
|
| Price |
$181.87
|
$25.56
|
| P/E Ratio |
22.54×
|
40.60×
|
| ROE |
-77.1%
|
19.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
38.8%
|
61.5%
|
| Debt / Equity |
-5.24×
|
1.04×
|
| Dividend Yield |
0.6%
|
0.0%
|
| RSI (14) |
49.2
|
20.6
|
| Beta |
0.547
|
1.236
|
| Expected Upside |
+17.5%
|
—
|
AI Committee View
Current Innellis committee reasoning for COKE versus UTI.
COKE leads by 10 points.
COKE scores 63/100 (Buy) versus UTI at 53/100 (Watch).
COKE Committee View
60% agreement
5 analysts
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- ROE of 39.6% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Price-to-book of 7.8x prices in significant intangible value — Value
- EPS declining -60.2% YoY despite any revenue growth — Growth
UTI Committee View
67% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — rsi at 21 is in oversold territory (could mean either capitulation or a bounce setup). This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock — Risk
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 37.4 is moderate-to-rich — Value
- Price-to-book of 5.4x prices in significant intangible value — Value
- EPS declining -25.9% YoY despite any revenue growth — Growth